BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 3:52:00 PM | Browse: 399 | Download: 324
Publication Name World Journal of Gastroenterology
Manuscript ID 4676
Country of Manuscript Source Italy
Received
2013-07-15 12:00
Peer-Review Started
2013-07-15 14:53
To Make the First Decision
2013-08-21 18:47
Return for Revision
2013-08-27 15:41
Revised
2013-09-20 00:17
Second Decision
2013-11-04 17:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-05 10:05
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-12-13 18:51
Publish the Manuscript Online
2014-01-19 14:17
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Letter to the Editor
Article Title Fecal calprotectin in coeliac disease
Manuscript Source Invited Manuscript
All Author List Pietro Capone, Antonio Rispo, Nicola Imperatore, Nicola Caporaso and Raffaella Tortora
Funding Agency and Grant Number
Corresponding author Pietro Capone, MD, Gastroenterologia, Department of Clinical Medicine and Surgery, University “Federico Ⅱ” of Naples, Via S. Pansini 5, 80131 Napoli, Italy. pietrocapone@hotmail.com
Keywords Coeliac disease; Calprotectin; Bowel inflammation; Small bowel
Core Tip High levels of fecal calprotectin (FC) have been found in several gastrointestinal diseases but only few and discordant reports investigated the role of FC in celiac disease (CD). So, we would like to share with the readers the results of our experience in 50 CD patients, who were referred to our third-level CD Unit. We think that FC is not able to investigate the subclinical inflammatory changes of active CD and FC should be considered a useless tool in the diagnostic work-up of uncomplicated CD but it should be accompanied by aTg when ruling out organic disease in patients with IBS.
Publish Date 2014-01-19 14:17
Citation Capone P, Rispo A, Imperatore N, Caporaso N, Tortora R. Fecal calprotectin in coeliac disease. World J Gastroenterol 2014; 20(2): 611-612
Url http://www.wjgnet.com/1007-9327/full/v20/i2/611.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i2.611
Full Article (PDF) WJG-20-611.pdf
Full Article (Word) WJG-20-611.doc
Manuscript File 4676-Review.doc
Answering Reviewers 4676-Answering reviewers.pdf
Copyright License Agreement 4676-Copyright assignment.pdf
Peer-review Report 4676-Peer review(s).pdf
Scientific Editor Work List 4676-Scientific editor work list.doc